Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Pulmatrix stock in Canada | $0.931
Own Pulmatrix shares in just a few minutes.
Pulmatrix is a biotechnology business based in the US. Pulmatrix stocks (PULM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.948 – an increase of 1.53% over the previous week. Pulmatrix employs 20 staff and has a trailing 12-month revenue of around $11.3 million.
How to buy Pulmatrix stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PULM in this case.
- Research Pulmatrix stocks. The platform should provide the latest information available.
- Buy your Pulmatrix stocks. It's that simple.
What's in this guide?
- Can I buy shares in Pulmatrix?
- Has coronavirus impacted Pulmatrix shares?
- Pulmatrix shares summary
- Compare share dealing platforms
- Is Pulmatrix stock a buy or sell?
- Pulmatrix performance over time
- Can I short Pulmatrix shares?
- Pulmatrix's financials
- How volatile are Pulmatrix shares?
- Does Pulmatrix pay a dividend?
- Have Pulmatrix shares ever split?
- Other common questions
How has Coronavirus impacted Pulmatrix's stock price?
Since the stock market crash in March caused by coronavirus, Pulmatrix's stock price has had significant negative movement.
Its last market close was $0.931, which is 39.55% down on its pre-crash value of $1.54 and 3.44% up on the lowest point reached during the March crash when the stocks fell as low as $0.9.
If you had bought $1,000 worth of Pulmatrix stocks at the start of February 2020, those stocks would have been worth $778.44 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $557.48.
Pulmatrix stock priceUse our graph to track the performance of PULM stocks over time.
Pulmatrix stocks at a glance
|Latest market close||$0.931|
|52-week range||$0.82 - $2.21|
|50-day moving average||$0.9685|
|200-day moving average||$1.2148|
|Wall St. target price||$5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.467|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Pulmatrix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Pulmatrix price performance over time
|1 month (2021-07-01)||-8.73%|
|3 months (2021-04-30)||-2.00%|
|Revenue TTM||USD$11.3 million|
|Gross profit TTM||USD$-2,975,000|
|Return on assets TTM||-11.44%|
|Return on equity TTM||-58.9%|
|Market capitalisation||USD$47.6 million|
TTM: trailing 12 months
How to short and sell Pulmatrix stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PULM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 632,515 Pulmatrix stocks held short by investors – that's known as Pulmatrix's "short interest". This figure is 14.3% down from 737,633 last month.
There are a few different ways that this level of interest in shorting Pulmatrix stocks can be evaluated.
Pulmatrix's "short interest ratio" (SIR)
Pulmatrix's "short interest ratio" (SIR) is the quantity of Pulmatrix stocks currently shorted divided by the average quantity of Pulmatrix stocks traded daily (recently around 433229.45205479). Pulmatrix's SIR currently stands at 1.46. In other words for every 100,000 Pulmatrix stocks traded daily on the market, roughly 1460 stocks are currently held short.
However Pulmatrix's short interest can also be evaluated against the total number of Pulmatrix stocks, or, against the total number of tradable Pulmatrix stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pulmatrix's short interest could be expressed as 0.01% of the outstanding stocks (for every 100,000 Pulmatrix stocks in existence, roughly 10 stocks are currently held short) or 0.012% of the tradable stocks (for every 100,000 tradable Pulmatrix stocks, roughly 12 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Pulmatrix.
Find out more about how you can short Pulmatrix stock.
Pulmatrix stock dividends
We're not expecting Pulmatrix to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Pulmatrix stocks ever split?
Pulmatrix stocks were split on a 1:10 basis on 6 February 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pulmatrix stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Pulmatrix stocks which in turn could have impacted Pulmatrix's stock price.
Pulmatrix stock price volatility
Over the last 12 months, Pulmatrix's stocks have ranged in value from as little as $0.82 up to $2.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pulmatrix's is 1.3841. This would suggest that Pulmatrix's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pulmatrix, Inc., a clinical stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug that is in Phase 2b clinical trials for the prevention and treatment of fungal infections and allergic/hypersensitivity reactions to fungus in patients with severe lung diseases comprising asthma, cystic fibrosis, and allergic bronchopulmonary aspergillosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with lung cancer and chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
Stocks similar to Pulmatrix
Pulmatrix in the news
Earnings Preview: Pulmatrix, Inc. (PULM) Q2 Earnings Expected to Decline
Pulmatrix appoints Director Anand Varadan
Pulmatrix appoints Director Anand Varadan
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to invest $1 million
Here are the top 5 ways you should invest $1 million.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada when it goes public
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.